Welcome to our dedicated page for Smith & Nephew news (Ticker: SNN), a resource for investors and traders seeking the latest updates and insights on Smith & Nephew stock.
Smith & Nephew plc reports news as a global medical technology company focused on the repair, regeneration and replacement of soft and hard tissue. Coverage centers on Orthopaedics, Sports Medicine & ENT and Advanced Wound Management, including wound dressings, negative pressure wound therapy, cartilage and rotator cuff repair implants, orthopedic reconstruction, trauma and extremities products, and surgical robotics.
Recurring developments include product launches and clinical evidence for ALLEVYN COMPLETE CARE, RENASYS EDGE, CARTIHEAL AGILI-C, REGENETEN, CORI, AETOS and related platforms; conference showcases; distribution agreements; segment performance updates; share buybacks; and governance matters tied to the company’s London-listed shares and NYSE-traded ADRs.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
On April 24, 2023, Smith+Nephew (LSE:SN, NYSE:SNN) unveiled the CORI™ Digital Tensioner, a groundbreaking device designed for robotic-assisted knee surgeries. This innovative technology allows surgeons to measure ligament tension before bone cutting, enhancing surgical precision and reducing variability by 64% compared to manual methods. The tensioner provides quantifiable joint laxity data, facilitating better surgical planning. Dr. Steven Haas praised the device for its capability to deliver objective gap data, marking a significant advancement in knee replacement procedures. The first commercial use occurred in Arizona, highlighting its practical application in a clinical setting. This launch underscores Smith+Nephew's commitment to improving patient outcomes through innovative technologies.
On March 23, 2023, Smith+Nephew (NYSE:SNN) announced promising results from a meta-analysis of 17 studies involving over 6,500 patients, highlighting the effectiveness of its COBLATION Intracapsular Tonsillectomy (CIT) technique. The study reveals that CIT leads to significantly better post-operative outcomes compared to total tonsillectomy, including a 64% reduction in post-operative complications, shorter pain duration, and quicker recovery times. This innovative technique is gaining popularity among pediatric otolaryngologists, reflecting the company's commitment to improving surgical tools for better patient care.
Smith+Nephew (LSE:SN, NYSE:SNN) announced its participation in the American Academy of Orthopaedic Surgeons 2023 Annual Meeting in Las Vegas, showcasing innovative technologies in Sports Medicine. Key highlights include:
- UltraTRAC™ QUAD ACL Reconstruction Technique: Offers advanced solutions for ligament grafting.
- INTELLIO™ Tablet: A device for streamlined surgical connectivity.
- CAP-FIX™ Capsular Management Family: Enhances efficiency in capsular procedures.
- REGENETEN™ Bioinductive Implant: Promotes natural healing for tendon repair.
These products aim to improve surgical outcomes and patient recovery.